After weeks of intense discussions on possible mergers among the five biggest U.S. health insurers, Aetna announced it would buy Humana in a deal valued at $37 billion -- the largest insurance...
Celgene Corp. will make an initial payment of about $1 billion, including a stock purchase, as part of a 10-year collaboration with fellow biotech company Juno Therapeutics Inc. on cancer and...
Johnson and Johnson has 10 new products in the pharmaceutical pipeline that could potentially earn the company $10 billion in revenue, according to CEO Alec Gorsky.
The Food and Drug Administration is close to approving new injectable drugs that don’t contain statins to lower LDL cholesterol, often referred to as ‘bad’ cholesterol.
NIH’S top doctor talks candidly about his fight for an AIDS-Free Generation and the ‘breathtaking’ advances we’ve made in treatments.
Scientists are mapping the Cannabis genome to increase understanding of the versatile plant’s many mutations, a marijuana version of the hugely influential Human Genome Project.
Federal health advisers on Tuesday recommended approval for a highly anticipated cholesterol drug from Sanofi and Regeneron Pharmaceuticals, but with the caveat that more data is needed about its...
FOX Business looks at the top five most expensive drugs on the market in the United States, based on cost per patient per year.
FOX Business looks at the top five most prescribed drugs in the United States, two of which treat high blood pressure.
U.S. Deaths are spiking from overdose related to heroin, Vicodin and OxyContin. But there is hope, as a drug called naloxone (aka Narcan) has been effective in keeping people alive following an OD.